Great Lakes Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-101,075
Closed -$3.63M 621
2020
Q1
$3.63M Sell
101,075
-1,573
-2% -$89.4K 0.11% 210
2019
Q4
$7.28M Buy
102,648
+1,301
+1% +$94.4K 0.16% 168
2019
Q3
$7.58M Buy
101,347
+3,627
+4% +$307K 0.17% 147
2019
Q2
$7.88M Buy
97,720
+4,173
+4% +$293K 0.17% 142
2019
Q1
$6.26M Buy
93,547
+27,448
+42% +$2.08M 0.14% 167
2018
Q4
$4.92M Buy
66,099
+10,916
+20% +$901K 0.12% 194
2018
Q3
$5.08M Sell
55,183
-6,511
-11% -$620K 0.11% 193
2018
Q2
$6.07M Sell
61,694
-208
-0.3% -$23.3K 0.14% 165
2018
Q1
$6.9M Buy
61,902
+17,847
+41% +$2M 0.16% 140
2017
Q4
$4.53M Buy
44,055
+6,013
+16% +$599K 0.1% 180
2017
Q3
$3.58M Buy
38,042
+3,117
+9% +$246K 0.08% 202
2017
Q2
$2.72M Buy
34,925
+6,545
+23% +$492K 0.07% 243
2017
Q1
$2.27M Buy
28,380
+4,447
+19% +$353K 0.06% 253
2016
Q4
$1.89M Buy
+23,933
New +$1.86M 0.05% 275

Other funds holding CMD

Great Lakes Advisors's CMD Position: Q2 2020 in Review

Great Lakes Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 101,075 shares — an estimated $3.63M sold.

Great Lakes Advisors first reported a position in CMD in Q4 2016 and held it in 14 quarters. The position peaked at $7.88M in Q2 2019. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

  • Great Lakes Advisors reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • Great Lakes Advisors sold 101,075 Cantel Medical Corporation shares in Q2 2020, an estimated $3.63M.
  • Great Lakes Advisors first reported a position in Cantel Medical Corporation in Q4 2016 and held it in 14 quarters.
  • Great Lakes Advisors's Cantel Medical Corporation position peaked at $7.88M in Q2 2019.
  • 210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Great Lakes Advisors's 13F filing for Q2 2020, filed 7 Aug 2020.